UNIQURE RECEIVES FDA REGENERATIVE MEDICINE ADVANCED THERAPY (RMAT) DESIGNATION FOR INVESTIGATIONAL GENE THERAPY AMT-130 IN HUNTINGTON’S DISEASE

Reuters · 06/03 11:07
UNIQURE RECEIVES FDA REGENERATIVE MEDICINE ADVANCED THERAPY (RMAT) DESIGNATION FOR INVESTIGATIONAL GENE THERAPY AMT-130 IN HUNTINGTON’S DISEASE